ΔNp63 has been recently involved in self-renewal potential of breast cancer stem cells. Although the p63 transcriptional profile has been extensively characterized, our knowledge of the p63-binding partners potentially involved in the regulation of breast tumour progression is limited. Here, we performed the yeast two hybrid approach to identify p63α interactors involved in breast tumorigenesis and we found that SETDB1, a histone lysine methyl transferases, interacts with ΔNp63α and that this interaction contributes to p63 protein stability. SETDB1 is often amplified in primary breast tumours, and its depletion confers to breast cancer cells growth disadvantage. We identified a list of thirty genes repressed by ΔNp63 in a SETDB1-dependent manner, whose expression is positively correlated to survival of breast cancer patients. These results suggest that p63 and SETDB1 expression, together with the repressed genes, may have diagnostic and prognostic potential.

Regina, C., Compagnone, M., Peschiaroli, A., Lena, A.m., Annicchiarico-Petruzzelli, M., Piro, M.c., et al. (2016). Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis. ONCOTARGET, 7(20), 28836-28848 [10.18632/oncotarget.7089].

Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis

Regina C.;COMPAGNONE, MIRCO;Lena A. M.;Piro M. C.;Melino G.;Candi E.
2016-05-01

Abstract

ΔNp63 has been recently involved in self-renewal potential of breast cancer stem cells. Although the p63 transcriptional profile has been extensively characterized, our knowledge of the p63-binding partners potentially involved in the regulation of breast tumour progression is limited. Here, we performed the yeast two hybrid approach to identify p63α interactors involved in breast tumorigenesis and we found that SETDB1, a histone lysine methyl transferases, interacts with ΔNp63α and that this interaction contributes to p63 protein stability. SETDB1 is often amplified in primary breast tumours, and its depletion confers to breast cancer cells growth disadvantage. We identified a list of thirty genes repressed by ΔNp63 in a SETDB1-dependent manner, whose expression is positively correlated to survival of breast cancer patients. These results suggest that p63 and SETDB1 expression, together with the repressed genes, may have diagnostic and prognostic potential.
mag-2016
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/11 - BIOLOGIA MOLECOLARE
English
Con Impact Factor ISI
SETDB1; breast cancer; histone methyl transferase; p63; proliferation; Breast Neoplasms; Cell Transformation, Neoplastic; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Membrane Proteins; Protein Methyltransferases
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=7089&pubmed-linkout=1
Regina, C., Compagnone, M., Peschiaroli, A., Lena, A.m., Annicchiarico-Petruzzelli, M., Piro, M.c., et al. (2016). Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis. ONCOTARGET, 7(20), 28836-28848 [10.18632/oncotarget.7089].
Regina, C; Compagnone, M; Peschiaroli, A; Lena, Am; Annicchiarico-Petruzzelli, M; Piro, Mc; Melino, G; Candi, E
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/199424
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 39
social impact